SlideShare une entreprise Scribd logo
1  sur  7
Télécharger pour lire hors ligne
Biosimilars - Regulatory Framework And Pipeline Analysis
MarketResearchReports.Biz presents this most up-to-date research on "Biosimilars -
Regulatory Framework And Pipeline Analysis"
Biosimilars are copied versions of biologics that offer a 20-50% reduction in cost compared
with innovative biologic products. Biosimilars are getting the world wide attention as the
cost of the innovative biologics are enormously high and even minimal reduction in price
will reduce the healthcare spending substantially. All the countries are focusing on
reducing the healthcare expenditure and biosimilars compliments to this goal. Biologic
products are complex in structure and follow a complex manufacturing process thus, some
variation exists between the reference product and its biosimilar. It is very important to
assess the variations in biosimilars by comparing with reference product to ensure quality,
non-clinical, and clinical properties, which has given rise to the regulatory requirements for
biosimilars.
Regulatory requirement for approving biosimilars varies across different regulatory bodies.
However, all the countries have derived the basic theme from EMA and WHO guidelines for
framing their regulatory structure. There is a need to harmonize the nomenclature of
biosimilars, extrapolation of indications, and interchangeability of biosimilars with
reference products across the regulatory bodies. Biosimilars market is developing and it
could be well established with the pipeline that is poised to deliver a wave of biosimilars in
the market in the near future
Get The Sample Copy Of This Report:
http://www.marketresearchreports.biz/sample/sample/286559
Scope
The scope of the report includes:
Introduction
Market dynamics: Trends, Drivers, and Barriers
WHO guidance for biosimilars
Regulatory overview, biosimilar guidelines, regulatory framework for biosimilars, and
market outlook for:
Europe
USA
India
South Korea
Japan
China
Key players
Pipeline Analysis
Overview
By Stage of Development / Molecule / Therapy Area / Indication
Late-Stage / Phase II / Phase I Pipeline Biosimilars
Reasons To Buy
The report will enhance your decision-making capability by allowing you to:
Understand the regulatory requirement and regulatory framework that facilitates effective
product development strategy as biosimilars industry is currently highly focused, growing,
and outpacing the growth rate of small molecule pharmaceutical market
Targeting geographies would be easy by comparing different regulatory frameworks; this
would also provide a base for designing a strategy to enter the developed markets.
Biosimilars are of interest in developed countries to reduce the healthcare expenditure
With the recent approvals of biosimilars by USFDA, the biosimilars market is going to grow
and this report examines the post approval market landscape
Examine the biosimilars pipeline and specifies the products that are highly targeted, it also
includes analysis of highly focused indications, mechanism of actions, and therapy areas
in the pipeline
Analyze the details of the clinical pipeline that includes late stage products, Phase II, and
Phase I products. Detailed understanding of the pipeline will help in targeting the products
for development, rate the current products and predict the competition
About us
MarketResearchReports.biz is the most comprehensive collection of market
research reports. MarketResearchReports.Biz services are specially designed to
save time and money for our clients. We are a one stop solution for all your
research needs, our main offerings are syndicated research reports, custom
research, subscription access and consulting services. We serve all sizes and types
of companies spanning across various industries.
To View The Top Related News:
http://www.marketresearchreports.biz/articles
Contact US:
Office: United States
State Tower
90 State Street, Suite 700
Albany, NY 12207
United States
Toll Free: 866-997-4948
Tel: +1-518-618-1030
E: sales@marketresearchreports.biz

Contenu connexe

En vedette

En vedette (9)

Service marketing - Critical Analysis of Goibibo Services
Service marketing - Critical Analysis of Goibibo ServicesService marketing - Critical Analysis of Goibibo Services
Service marketing - Critical Analysis of Goibibo Services
 
The 5 Metrics for Growing Your Team Effectively
The 5 Metrics for Growing Your Team EffectivelyThe 5 Metrics for Growing Your Team Effectively
The 5 Metrics for Growing Your Team Effectively
 
Sales Hacker Workshop SF: Build a High Velocity Sales Machine
Sales Hacker Workshop SF: Build a High Velocity Sales MachineSales Hacker Workshop SF: Build a High Velocity Sales Machine
Sales Hacker Workshop SF: Build a High Velocity Sales Machine
 
Writing data analysis pipeline as ruby gem
Writing data analysis pipeline as ruby gemWriting data analysis pipeline as ruby gem
Writing data analysis pipeline as ruby gem
 
General pipeline of transcriptomics analysis
General pipeline of transcriptomics analysisGeneral pipeline of transcriptomics analysis
General pipeline of transcriptomics analysis
 
Visualising Data with Code
Visualising Data with CodeVisualising Data with Code
Visualising Data with Code
 
Working With Big Data
Working With Big DataWorking With Big Data
Working With Big Data
 
Analytics Trends 2016: The next evolution
Analytics Trends 2016: The next evolutionAnalytics Trends 2016: The next evolution
Analytics Trends 2016: The next evolution
 
Booz Allen Field Guide to Data Science
Booz Allen Field Guide to Data Science Booz Allen Field Guide to Data Science
Booz Allen Field Guide to Data Science
 

Dernier

Cloud Frontiers: A Deep Dive into Serverless Spatial Data and FME
Cloud Frontiers:  A Deep Dive into Serverless Spatial Data and FMECloud Frontiers:  A Deep Dive into Serverless Spatial Data and FME
Cloud Frontiers: A Deep Dive into Serverless Spatial Data and FME
Safe Software
 
Modular Monolith - a Practical Alternative to Microservices @ Devoxx UK 2024
Modular Monolith - a Practical Alternative to Microservices @ Devoxx UK 2024Modular Monolith - a Practical Alternative to Microservices @ Devoxx UK 2024
Modular Monolith - a Practical Alternative to Microservices @ Devoxx UK 2024
Victor Rentea
 

Dernier (20)

Apidays New York 2024 - Passkeys: Developing APIs to enable passwordless auth...
Apidays New York 2024 - Passkeys: Developing APIs to enable passwordless auth...Apidays New York 2024 - Passkeys: Developing APIs to enable passwordless auth...
Apidays New York 2024 - Passkeys: Developing APIs to enable passwordless auth...
 
Spring Boot vs Quarkus the ultimate battle - DevoxxUK
Spring Boot vs Quarkus the ultimate battle - DevoxxUKSpring Boot vs Quarkus the ultimate battle - DevoxxUK
Spring Boot vs Quarkus the ultimate battle - DevoxxUK
 
DBX First Quarter 2024 Investor Presentation
DBX First Quarter 2024 Investor PresentationDBX First Quarter 2024 Investor Presentation
DBX First Quarter 2024 Investor Presentation
 
Apidays New York 2024 - Scaling API-first by Ian Reasor and Radu Cotescu, Adobe
Apidays New York 2024 - Scaling API-first by Ian Reasor and Radu Cotescu, AdobeApidays New York 2024 - Scaling API-first by Ian Reasor and Radu Cotescu, Adobe
Apidays New York 2024 - Scaling API-first by Ian Reasor and Radu Cotescu, Adobe
 
"I see eyes in my soup": How Delivery Hero implemented the safety system for ...
"I see eyes in my soup": How Delivery Hero implemented the safety system for ..."I see eyes in my soup": How Delivery Hero implemented the safety system for ...
"I see eyes in my soup": How Delivery Hero implemented the safety system for ...
 
Apidays New York 2024 - The value of a flexible API Management solution for O...
Apidays New York 2024 - The value of a flexible API Management solution for O...Apidays New York 2024 - The value of a flexible API Management solution for O...
Apidays New York 2024 - The value of a flexible API Management solution for O...
 
Cloud Frontiers: A Deep Dive into Serverless Spatial Data and FME
Cloud Frontiers:  A Deep Dive into Serverless Spatial Data and FMECloud Frontiers:  A Deep Dive into Serverless Spatial Data and FME
Cloud Frontiers: A Deep Dive into Serverless Spatial Data and FME
 
Repurposing LNG terminals for Hydrogen Ammonia: Feasibility and Cost Saving
Repurposing LNG terminals for Hydrogen Ammonia: Feasibility and Cost SavingRepurposing LNG terminals for Hydrogen Ammonia: Feasibility and Cost Saving
Repurposing LNG terminals for Hydrogen Ammonia: Feasibility and Cost Saving
 
Rising Above_ Dubai Floods and the Fortitude of Dubai International Airport.pdf
Rising Above_ Dubai Floods and the Fortitude of Dubai International Airport.pdfRising Above_ Dubai Floods and the Fortitude of Dubai International Airport.pdf
Rising Above_ Dubai Floods and the Fortitude of Dubai International Airport.pdf
 
[BuildWithAI] Introduction to Gemini.pdf
[BuildWithAI] Introduction to Gemini.pdf[BuildWithAI] Introduction to Gemini.pdf
[BuildWithAI] Introduction to Gemini.pdf
 
DEV meet-up UiPath Document Understanding May 7 2024 Amsterdam
DEV meet-up UiPath Document Understanding May 7 2024 AmsterdamDEV meet-up UiPath Document Understanding May 7 2024 Amsterdam
DEV meet-up UiPath Document Understanding May 7 2024 Amsterdam
 
Modular Monolith - a Practical Alternative to Microservices @ Devoxx UK 2024
Modular Monolith - a Practical Alternative to Microservices @ Devoxx UK 2024Modular Monolith - a Practical Alternative to Microservices @ Devoxx UK 2024
Modular Monolith - a Practical Alternative to Microservices @ Devoxx UK 2024
 
Corporate and higher education May webinar.pptx
Corporate and higher education May webinar.pptxCorporate and higher education May webinar.pptx
Corporate and higher education May webinar.pptx
 
Apidays New York 2024 - The Good, the Bad and the Governed by David O'Neill, ...
Apidays New York 2024 - The Good, the Bad and the Governed by David O'Neill, ...Apidays New York 2024 - The Good, the Bad and the Governed by David O'Neill, ...
Apidays New York 2024 - The Good, the Bad and the Governed by David O'Neill, ...
 
Apidays New York 2024 - APIs in 2030: The Risk of Technological Sleepwalk by ...
Apidays New York 2024 - APIs in 2030: The Risk of Technological Sleepwalk by ...Apidays New York 2024 - APIs in 2030: The Risk of Technological Sleepwalk by ...
Apidays New York 2024 - APIs in 2030: The Risk of Technological Sleepwalk by ...
 
TrustArc Webinar - Unlock the Power of AI-Driven Data Discovery
TrustArc Webinar - Unlock the Power of AI-Driven Data DiscoveryTrustArc Webinar - Unlock the Power of AI-Driven Data Discovery
TrustArc Webinar - Unlock the Power of AI-Driven Data Discovery
 
Web Form Automation for Bonterra Impact Management (fka Social Solutions Apri...
Web Form Automation for Bonterra Impact Management (fka Social Solutions Apri...Web Form Automation for Bonterra Impact Management (fka Social Solutions Apri...
Web Form Automation for Bonterra Impact Management (fka Social Solutions Apri...
 
Strategize a Smooth Tenant-to-tenant Migration and Copilot Takeoff
Strategize a Smooth Tenant-to-tenant Migration and Copilot TakeoffStrategize a Smooth Tenant-to-tenant Migration and Copilot Takeoff
Strategize a Smooth Tenant-to-tenant Migration and Copilot Takeoff
 
Biography Of Angeliki Cooney | Senior Vice President Life Sciences | Albany, ...
Biography Of Angeliki Cooney | Senior Vice President Life Sciences | Albany, ...Biography Of Angeliki Cooney | Senior Vice President Life Sciences | Albany, ...
Biography Of Angeliki Cooney | Senior Vice President Life Sciences | Albany, ...
 
Apidays New York 2024 - Accelerating FinTech Innovation by Vasa Krishnan, Fin...
Apidays New York 2024 - Accelerating FinTech Innovation by Vasa Krishnan, Fin...Apidays New York 2024 - Accelerating FinTech Innovation by Vasa Krishnan, Fin...
Apidays New York 2024 - Accelerating FinTech Innovation by Vasa Krishnan, Fin...
 

Biosimilars Industry Analysis - Market Size, Shares, Trends, Growth, Forecast, Regulatory Framework And Pipeline Analysis

  • 1. Biosimilars - Regulatory Framework And Pipeline Analysis MarketResearchReports.Biz presents this most up-to-date research on "Biosimilars - Regulatory Framework And Pipeline Analysis" Biosimilars are copied versions of biologics that offer a 20-50% reduction in cost compared with innovative biologic products. Biosimilars are getting the world wide attention as the cost of the innovative biologics are enormously high and even minimal reduction in price
  • 2. will reduce the healthcare spending substantially. All the countries are focusing on reducing the healthcare expenditure and biosimilars compliments to this goal. Biologic products are complex in structure and follow a complex manufacturing process thus, some variation exists between the reference product and its biosimilar. It is very important to assess the variations in biosimilars by comparing with reference product to ensure quality, non-clinical, and clinical properties, which has given rise to the regulatory requirements for biosimilars. Regulatory requirement for approving biosimilars varies across different regulatory bodies. However, all the countries have derived the basic theme from EMA and WHO guidelines for framing their regulatory structure. There is a need to harmonize the nomenclature of biosimilars, extrapolation of indications, and interchangeability of biosimilars with reference products across the regulatory bodies. Biosimilars market is developing and it could be well established with the pipeline that is poised to deliver a wave of biosimilars in the market in the near future
  • 3. Get The Sample Copy Of This Report: http://www.marketresearchreports.biz/sample/sample/286559 Scope The scope of the report includes: Introduction Market dynamics: Trends, Drivers, and Barriers WHO guidance for biosimilars Regulatory overview, biosimilar guidelines, regulatory framework for biosimilars, and market outlook for: Europe USA India South Korea Japan
  • 4. China Key players Pipeline Analysis Overview By Stage of Development / Molecule / Therapy Area / Indication Late-Stage / Phase II / Phase I Pipeline Biosimilars Reasons To Buy The report will enhance your decision-making capability by allowing you to: Understand the regulatory requirement and regulatory framework that facilitates effective product development strategy as biosimilars industry is currently highly focused, growing, and outpacing the growth rate of small molecule pharmaceutical market Targeting geographies would be easy by comparing different regulatory frameworks; this would also provide a base for designing a strategy to enter the developed markets. Biosimilars are of interest in developed countries to reduce the healthcare expenditure
  • 5. With the recent approvals of biosimilars by USFDA, the biosimilars market is going to grow and this report examines the post approval market landscape Examine the biosimilars pipeline and specifies the products that are highly targeted, it also includes analysis of highly focused indications, mechanism of actions, and therapy areas in the pipeline Analyze the details of the clinical pipeline that includes late stage products, Phase II, and Phase I products. Detailed understanding of the pipeline will help in targeting the products for development, rate the current products and predict the competition About us MarketResearchReports.biz is the most comprehensive collection of market research reports. MarketResearchReports.Biz services are specially designed to save time and money for our clients. We are a one stop solution for all your research needs, our main offerings are syndicated research reports, custom
  • 6. research, subscription access and consulting services. We serve all sizes and types of companies spanning across various industries. To View The Top Related News: http://www.marketresearchreports.biz/articles Contact US: Office: United States State Tower 90 State Street, Suite 700
  • 7. Albany, NY 12207 United States Toll Free: 866-997-4948 Tel: +1-518-618-1030 E: sales@marketresearchreports.biz